ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $476,092 | +21.2% | 8,200 | +12.3% | 0.01% | +22.2% |
Q2 2023 | $392,959 | +73.6% | 7,300 | +28.1% | 0.01% | +50.0% |
Q1 2023 | $226,404 | +97069.1% | 5,700 | -1.7% | 0.01% | 0.0% |
Q4 2022 | $233 | -99.9% | 5,800 | -6.5% | 0.01% | +20.0% |
Q1 2022 | $203,000 | -15.4% | 6,200 | +19.2% | 0.01% | 0.0% |
Q4 2021 | $240,000 | -3.2% | 5,200 | +52.9% | 0.01% | -61.5% |
Q3 2019 | $248,000 | -1.6% | 3,400 | +9.7% | 0.01% | 0.0% |
Q2 2019 | $252,000 | +15.1% | 3,100 | 0.0% | 0.01% | +18.2% |
Q1 2019 | $219,000 | +7.4% | 3,100 | -13.9% | 0.01% | +22.2% |
Q3 2018 | $204,000 | -25.5% | 3,600 | -12.2% | 0.01% | -25.0% |
Q2 2018 | $274,000 | +17.6% | 4,100 | +2.5% | 0.01% | +9.1% |
Q1 2018 | $233,000 | -7.2% | 4,000 | +2.6% | 0.01% | 0.0% |
Q4 2017 | $251,000 | +8.2% | 3,900 | +11.4% | 0.01% | -8.3% |
Q3 2016 | $232,000 | +4.0% | 3,500 | -2.8% | 0.01% | +9.1% |
Q2 2015 | $223,000 | -0.9% | 3,600 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $225,000 | – | 3,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |